| Literature DB >> 27324990 |
Andrew J Long1, Erik Sampson2, Richard W McCarthy2, Christopher M Harris2, Marc Barnard2, Dan Shi2, Donna Conlon2, Robert Caldwell3, David Honor2, Neil Wishart2, Michael Hoemann2, Lori Duggan2, Douglas Fritz2, Christopher Stedman2, Elizabeth O'Connor2, Igor Mikaelian2, Annette Schwartz2.
Abstract
Spleen tyrosine kinase (Syk) is a nonreceptor tyrosine kinase that is an important signaling enzyme downstream of immunoreceptors containing an intracellular immunoreceptor tyrosine activating motif (ITAM). These receptors encompass a wide variety of biological functions involved in autoimmune disease pathogenesis. There has been considerable interest in the development of inhibitors of the Syk pathway for the treatment of rheumatoid arthritis and systemic lupus erythematosus. We report that Syk inhibition mechanistically caused peri-islet hemorrhages and fibrin deposition in the rat pancreas and that this finding is due to a homeostatic functional defect in platelets. In more limited studies, similar lesions could not be induced in mice, dogs, and cynomolgus monkeys at similar or higher plasma drug concentrations. Irradiation-induced thrombocytopenia caused a phenotypically similar peri-islet pancreas lesion and the formation of this lesion could be prevented by platelet transfusion. In addition, Syk inhibitor-induced lesions were prevented by the coadministration of prednisone. A relatively greater sensitivity of rat platelets to Syk inhibition was supported by functional analyses demonstrating rat-specific differences in response to convulxin, a glycoprotein VI agonist that signals through Syk. These data demonstrate that the Syk pathway is critical in platelet-endothelial cell homeostasis in the peri-islet pancreatic microvasculature in rats.Entities:
Keywords: Syk; hemorrhage; islet; pancreas; platelet; rat; toxicity
Mesh:
Substances:
Year: 2016 PMID: 27324990 DOI: 10.1177/0192623316654015
Source DB: PubMed Journal: Toxicol Pathol ISSN: 0192-6233 Impact factor: 1.902